文献速递皮肤肿瘤

莫氏手术与广泛局部切除对躯干和四肢黑色素瘤总生存的关联

Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities.
PubMed 文献 · JAMA Dermatol · 2021-01-01

多变量分析显示,躯干、上肢、下肢及合并部位中两种手术的总生存无显著差异。

要点

  • 躯干和四肢黑色素瘤中,MMS与WLE的总生存无显著差异。
  • 阳性手术切缘、溃疡、高龄、合并症及非私营保险与死亡风险升高相关。
  • 女性及非结节亚型与更好的总生存相关。

核心结论

  • 与WLE相比,MMS治疗躯干和四肢黑色素瘤未显著改变总生存。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库2004至2015年去标识数据。
  • 患者平均年龄58.8岁(SD 16.0),男性占52.7%。

临床怎么用

  • 躯干和四肢黑色素瘤选择MMS或WLE时,总生存证据不支持MMS具有生存优势。
  • 应关注阳性切缘、溃疡、高龄、合并症及保险状态等预后相关因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Although previous database studies suggest that Mohs micrographic surgery (MMS) treatment is associated with improved overall survival (OS) for head and neck melanomas, outcomes for trunk and extremity (T&E) tumors have not been adequately evaluated. OBJECTIVE: To assess survival outcomes for patients with melanomas of the T&E treated with MMS vs wide local excision (WLE). DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study examined deidentified data from the National Cancer Database between 2004 and 2015. Inclusion criteria for the analysis included diagnosis of trunk, upper extremity, or lower extremity melanoma; known Breslow depth; removal by MMS or WLE; and known last date of survival status. MAIN OUTCOMES AND MEASURES: Five-year all-cause mortality (ACM) rates. RESULTS: A total of 188 862 in situ and invasive melanomas were included in the analysis (MMS, 2.3%; WLE, 97.7%); the mean (SD) age of patients included was 58.8 (16.0) years, and 52.7% were male. Multivariate analysis demonstrated no OS difference among trunk (WLE hazard ratio [HR], 1.097; 95% CI, 0.950-1.267; P = .21), upper extremity (WLE HR, 1.013; 95% CI, 0.872-1.176; P = .87), lower extremity (WLE HR, 0.934; 95% CI, 0.770-1.134; P = .49), or combined T&E (WLE HR, 1.031; 95% CI, 0.941-1.130; P = .51) tumors. Factors associated with increased risk of ACM on multivariate analysis of all tumors included increasing age (HR, 1.043; 95% CI, 1.042-1.044; P < .001), no insurance or nonprivate insurance (none: HR, 1.921 [95% CI, 1.782-2.071]; Medicaid: HR, 2.410 [95% CI, 2.242-2.591]; Medicare: HR, 1.237 [95% CI, 1.194-1.281]; other government insurance: HR, 1.279 [95% CI, 1.117-1.465]; P < .001 for all), positive surgical margins (HR, 1.609; 95% CI, 1.512-1.712; P < .001), a Charlson-Deyo comorbidity score greater than 0 (Charlson-Deyo score of 1: HR, 1.340; 95% CI, 1.295-1.385; P < .001; Charlson-Deyo score of ≥2: HR, 2.044; 95% CI, 1.934-2.159; P < .001), tumor ulceration (HR, 2.175; 95% CI, 2.114-2.238; P < .001), and increasing Breslow depth (HR, 1.002 [per 0.1 mm]; P < .001). Female sex (HR, 0.698; 95% CI, 0.680-0.716; P < .001) and nonnodular subtype (lentigo maligna/lentigo maligna melanoma: HR, 0.743; 95% CI, 0.686-0.805; P < .001; superficial spreading: HR, 0.739; 95% CI, 0.710-0.769; P < .001; other subtype: HR, 0.817; 95% CI, 0.790-0.845; P < .001; nodular: HR, 1 [reference]) were associated with improved OS. CONCLUSIONS AND RELEVANCE: This cohort study of patients surgically treated for melanomas of the trunk and/or extremities found that, compared with WLE, MMS was not associated with significantly different OS for T&E melanomas.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Demer AM, Hanson JL, Maher IA, et al. Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities. JAMA Dermatol. 2021. PMID: 33084853. doi:10.1001/jamadermatol.2020.3950

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。